The first children's hospital in the Yangtze River Delta and among the first nationwide to simultaneously possess both the National Clinical Research Center for Child Health and Diseases and the National Children's Regional Medical Center.

Ranked 2nd among children's hospitals nationwide in the 2022 national tertiary public hospital performance assessment, with the highest A rating for specialized hospitals; leading positions in the Fudan version of China Hospital Rankings Pediatrics.

First batch of national key disciplines in pediatrics under the Ministry of Education, possessing all national clinical key specialties in the pediatric field.

National Child Early Development Demonstration Base, National Birth Defect Diagnosis and Treatment International Science and Technology Cooperation Base, National Stem Cell Clinical Research Filing Institution, Ministry of Education Reproductive Genetics Key Laboratory, and other national-level platforms. NSFC project approvals grow at an average annual rate of 20%. 4 National Science and Technology Progress Second Prizes, 4 National Maternal and Child Health Technology Awards.

The Pediatric and Adolescent Gynecology (PAG) team became the first mainland China training and research center certified by FIGIJ (International Federation of Infantile and Juvenile Gynecology) in 2017, with qualifications to train global pediatric and adolescent gynecology doctors. Collaborations with over 10 countries including the UK, USA, Canada, Australia, and Belgium. Core Departments and Global Leadership

Da Vinci robotic surgical volume continues to lead all children's hospitals nationwide, with surgical success rates exceeding 99%. Pediatric minimally invasive robotic surgical volume and level firmly rank 1st nationwide. Conducts pediatric liver transplantation, kidney transplantation, and heart transplantation, building a pediatric major organ transplantation center. Leading nationwide in structural birth defect rescue, various difficult tumors, and critical neonatal rescue.

ECMO volume ranked 1st nationwide for three consecutive years, survival rates 10 percentage points higher than international levels. Created the nation's first pediatric heart failure research ward,刷新 national records for youngest age and lowest weight for artificial heart implantation.

Led by Professor Wang Wei, nationally leading in congenital heart disease interventional treatment and arrhythmia radiofrequency ablation technology. Conducts pediatric artificial heart implantation and complex congenital heart disease surgical treatment.

Leading in comprehensive treatment of pediatric leukemia, lymphoma, and solid tumors. Globally pioneered CAR-T cell therapy for autoimmune diseases with over 40 cases, the highest number worldwide.

Led by Chief Physician Tao Jinfan, nationally leading in minimally invasive treatment of complex neonatal surgical diseases including neonatal duodenal obstruction, high imperforate anus in infants, and short bowel syndrome.

Led by Chief Physician Wang Jinhu, digital 3D precision surgical planning systems applied to complex vascular-encased tumor resection, laparoscopic adrenal tumor resection with the largest single-center case volume domestically. Innovatively implemented ovarian tumor day surgery models.

Led by Director Sun Liying, the first mainland China FIGIJ-certified training and research center, cultivating over 100 PAG professional physicians for China and the Asia-Pacific region. Director Gao Huihui is the first and only IFEPAG researcher in mainland China.

Led by Chief Physician Li Jianhua, nationally leading in non-invasive diagnosis and treatment of pectus excavatum, minimally invasive small-incision ventricular septal defect closure, and laparoscopic treatment of congenital pulmonary cystic lesions.